Metabolic Profiling Defines Glioblastoma Subtypes with Distinct Prognoses and Therapeutic Vulnerabilities. Wu F, Yin YY, Wang D, Pan CQ, et al. Neuro Oncol 2026 Jan 2:noaf294. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wu F, Yin YY, Wang D, Pan CQ, et al. Metabolic Profiling Defines Glioblastoma Subtypes with Distinct Prognoses and Therapeutic Vulnerabilities. Neuro Oncol 2026 Jan 2:noaf294. doi: 10.1093.
PMID: 41485080